S-1: BIO-key International Files for Resale of Up to 436,509 Shares of Common Stock

BIO-key International is registering the resale of up to 436,509 shares of its common stock by a selling stockholder, Dillon Hill Investment Company LLC, with the company not receiving any proceeds from the sale.

Summary

• BIO-key International has filed a registration statement for the resale of up to 436,509 shares of its common stock.
• The shares are to be sold by Dillon Hill Investment Company LLC, a selling stockholder.
• The shares consist of 48,473 issued and outstanding shares, 126,131 shares issuable upon exercise of pre-funded warrants, and 261,905 shares issuable upon exercise of common warrants.
• BIO-key will not receive any proceeds from the sale of these shares by the selling stockholder.
• If all pre-funded and common warrants are exercised, BIO-key would receive gross proceeds of $825,290, which it intends to use for working capital.
• The common warrants will become exercisable on June 21, 2024, at an exercise price of $3.15 per share, while the pre-funded warrants are exercisable immediately at $0.018 per share.
• The selling stockholder is subject to blocker provisions that limit beneficial ownership to 4.99% or 9.99% of the company's outstanding common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment. The document primarily concerns the registration of shares for resale, with potential benefits from warrant exercises offset by risks of stock dilution and market volatility.

Positives

• The company could receive $825,290 in gross proceeds if all warrants are exercised.
• The funds are earmarked for working capital, which could support business operations.
• The registration statement allows the selling stockholder to sell shares in the public market, potentially increasing liquidity for those shares.

Negatives

• BIO-key will not receive any proceeds from the initial sale of shares by the selling stockholder.
• The sale of a substantial number of shares could lower the stock price.
• The market price of the common shares could decrease if stockholders sell substantial amounts of common shares.
• Investors will suffer dilution with any additional issuance of common shares.

Risks

• Sales of a substantial number of shares of common stock in the public market could lower the stock price and impair the company's ability to raise funds in new stock offerings.
• An active trading market for the company's shares may not be sustained.
• Investing in the company's securities involves a high degree of risk, and purchasers may lose their entire investment.
• The company's history of losses and limited revenue poses a risk to investors.
• The company's ability to raise additional capital is uncertain.
• The company faces competition in the biometric technology and identity access management industries.
• Market acceptance of biometric products generally and the company's products under development is uncertain.
• The company's ability to convert sales opportunities to customer contracts is uncertain.
• The company's ability to expand into Asia, Africa, and other foreign markets is uncertain.
• The company's ability to integrate the operations and personnel of Swivel Secure into its business is uncertain.
• Fluctuations in foreign currency exchange rates pose a risk to the company.
• The duration and extent of continued hostilities in Ukraine and its impact on the company's European customers pose a risk to the company.
• Delays in the development of products pose a risk to the company.

Future Outlook

The company expects to grow its business within highly-regulated industries and expects to continue to extend this footprint in 2024 and beyond. The company believes that continued heightened security and privacy requirements will generate increased demand for security solutions, including biometrics. The company expects that the compatible, yet superior portable biometric user experience offered by its technology for Windows 10 and 11 users will accelerate the demand for its computer network log-on solutions and fingerprint readers. Through value add-offerings via direct sales, resellers, and strategic partnerships with leading higher education platform providers, the company expects to continue to grow its installed base. Through Swivel Secure Europe, the company also expects to grow its business in EMEA.

Industry Context

The document highlights BIO-key's position in the identity and access management (IAM) market, particularly in biometric authentication. The company aims to differentiate itself from competitors by offering phone-less and token-less authentication methods, targeting industries with roving workers and shared workstations. The document also mentions the increasing adoption of MFA as a cybersecurity requirement, suggesting a growing market for BIO-key's solutions.

Comparison to Industry Standards

• The document positions BIO-key as offering a unique value proposition in the MFA market by providing phone-less and token-less biometric solutions, which contrasts with the more common phoneand token-based MFA solutions offered by competitors.
• The document highlights BIO-key's ability to integrate with existing FIDO devices, allowing enterprises to augment their authentication options with biometric choices.
• The document mentions that BIO-key's fingerprint biometric platform is certified by NIST and supports mixing and matching of different manufacturers' fingerprint scanners, providing customers with flexibility in selecting the right scanner for their specific use case.

Stakeholder Impact

• Shareholders may experience dilution if warrants are exercised and new shares are issued.
• The selling stockholder will have the opportunity to liquidate its position in the company.
• The company may benefit from the proceeds of warrant exercises, which could be used to fund operations and growth.

Next Steps

• The selling stockholder may sell the shares covered by the prospectus through public or private transactions.
• The company may receive proceeds from the exercise of warrants.
• The company will bear all costs, expenses, and fees in connection with the registration of the shares.

Key Dates

Keywords

common stock, warrants, resale, securities, offering, BIO-key, stockholder, registration